Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1984 Jul;77(7):585–594. doi: 10.1177/014107688407700712

Screening for familial medullary thyroid carcinoma: a review.

B A Ponder
PMCID: PMC1439939  PMID: 6747984

Full text

PDF
585

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baylin S. B., Wells S. A., Jr Management of hereditary medullary thyroid carcinoma. Clin Endocrinol Metab. 1981 Jul;10(2):367–378. doi: 10.1016/s0300-595x(81)80028-x. [DOI] [PubMed] [Google Scholar]
  2. Becker K. L., Silva O. L., Snider R. H., Moore C. F., Geelhoed G. W. The surgical implications of hypercalcitonemia. Surg Gynecol Obstet. 1982 Jun;154(6):897–908. [PubMed] [Google Scholar]
  3. Block M. A., Jackson C. E., Greenawald K. A., Yott J. B., Tashjian A. H., Jr Clinical characteristics distinguishing hereditary from sporadic medullary thyroid carcinoma. Treatment implications. Arch Surg. 1980 Feb;115(2):142–148. doi: 10.1001/archsurg.1980.01380020012004. [DOI] [PubMed] [Google Scholar]
  4. Body J. J., Heath H., 3rd Estimates of circulating monomeric calcitonin: physiological studies in normal and thyroidectomized man. J Clin Endocrinol Metab. 1983 Nov;57(5):897–903. doi: 10.1210/jcem-57-5-897. [DOI] [PubMed] [Google Scholar]
  5. Brown M. J., Allison D. J., Jenner D. A., Lewis P. J., Dollery C. T. Increased sensitivity and accuracy of phaeochromocytoma diagnosis achieved by use of plasma-adrenaline estimations and a pentolinium-suppression test. Lancet. 1981 Jan 24;1(8213):174–177. doi: 10.1016/s0140-6736(81)90058-1. [DOI] [PubMed] [Google Scholar]
  6. Carney J. A., Hayles A. B. Alimentary tract manifestations of multiple endocrine neoplasia, type 2b. Mayo Clin Proc. 1977 Sep;52(9):543–548. [PubMed] [Google Scholar]
  7. Carney J. A., Roth S. I., Heath H., 3rd, Sizemore G. W., Hayles A. B. The parathyroid glands in multiple endocrine neoplasia type 2b. Am J Pathol. 1980 May;99(2):387–398. [PMC free article] [PubMed] [Google Scholar]
  8. Cerny J. C., Jackson C. E., Talpos G. B., Yott J. B., Lee M. W. Pheochromocytoma in multiple endocrine neoplasia type II: an example of the two-hit theory of neoplasia. Surgery. 1982 Nov;92(5):849–852. [PubMed] [Google Scholar]
  9. Chong G. C., Beahrs O. H., Sizemore G. W., Woolner L. H. Medullary carcinoma of the thyroid gland. Cancer. 1975 Mar;35(3):695–704. doi: 10.1002/1097-0142(197503)35:3<695::aid-cncr2820350323>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
  10. Deftos L. J., Weisman M. H., Williams G. W., Karpf D. B., Frumar A. M., Davidson B. J., Parthemore J. G., Judd H. L. Influence of age and sex on plasma calcitonin in human beings. N Engl J Med. 1980 Jun 12;302(24):1351–1353. doi: 10.1056/NEJM198006123022407. [DOI] [PubMed] [Google Scholar]
  11. Dyck P. J., Carney J. A., Sizemore G. W., Okazaki H., Brimijoin W. S., Lambert E. H. Multiple endocrine neoplasia, type 2b: phenotype recognition; neurological features and their pathological basis. Ann Neurol. 1979 Oct;6(4):302–314. doi: 10.1002/ana.410060404. [DOI] [PubMed] [Google Scholar]
  12. Dymling J. F., Ljungberg O., Hillyard C. J., Greenberg P. B., Evans I. M., MacIntyre I. Whisky: a new provacative test for calcitonin secretion. Acta Endocrinol (Copenh) 1976 Jul;82(3):500–509. doi: 10.1530/acta.0.0820500. [DOI] [PubMed] [Google Scholar]
  13. Emmertsen K. K., Nielsen H. E., Mosekilde L., Hansen H. H. Pentagastrin, calcium and whisky stimulated serum calcitonin in medullary carcinoma of the thyroid. Acta Radiol Oncol. 1980;19(2):85–89. doi: 10.3109/02841868009130138. [DOI] [PubMed] [Google Scholar]
  14. Emmertsen K., Elbrønd O., Nielsen H. E., Mosekilde L., Charles P., Kaae S., Hansen H. H. Familial medullary thyroid carcinoma in multiple endocrine neoplasia (MEN) IIa: diagnosis and problems in treatment. Eur J Cancer Clin Oncol. 1982 Jul;18(7):645–650. doi: 10.1016/0277-5379(82)90210-3. [DOI] [PubMed] [Google Scholar]
  15. Emmertsen K., Ernø H., Henriques U., Schrøder H. D. C-cells for differentiation between familial and sporadic medullary thyroid carcinoma. Dan Med Bull. 1983 Sep;30(5):353–356. [PubMed] [Google Scholar]
  16. Fletcher D. R. Medullary carcinoma of thyroid and phaeochromocytoma. J R Soc Med. 1978 Apr;71(4):289–291. doi: 10.1177/014107687807100416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gagel R. F., Jackson C. E., Block M. A., Feldman Z. T., Reichlin S., Hamilton B. P., Tashjian A. H., Jr Age-related probability of development of hereditary medullary thyroid carcinoma. J Pediatr. 1982 Dec;101(6):941–946. doi: 10.1016/s0022-3476(82)80014-0. [DOI] [PubMed] [Google Scholar]
  18. Gorlin R. J., Sedano H. O., Vickers R. A., Cervenka J. Multiple mucosal neuromas, pheochromocytoma and medullary carcinoma of the thyroid--a syndrome. Cancer. 1968 Aug;22(2):293–passim. doi: 10.1002/1097-0142(196808)22:2<293::aid-cncr2820220206>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  19. Graze K., Spiler I. J., Tashjian A. H., Jr, Melvin K. E., Cervi-Skinner S., Gagel R. F., Miller H. H., Wolfe H. J., DeLellis R. A., Leape L. Natural history of familial medullary thyroid carcinoma: effect of a program for early diagnosis. N Engl J Med. 1978 Nov 2;299(18):980–985. doi: 10.1056/NEJM197811022991804. [DOI] [PubMed] [Google Scholar]
  20. Gusella J. F., Wexler N. S., Conneally P. M., Naylor S. L., Anderson M. A., Tanzi R. E., Watkins P. C., Ottina K., Wallace M. R., Sakaguchi A. Y. A polymorphic DNA marker genetically linked to Huntington's disease. Nature. 1983 Nov 17;306(5940):234–238. doi: 10.1038/306234a0. [DOI] [PubMed] [Google Scholar]
  21. Heath H., 3rd, Sizemore G. W. Radioimmunoassay for calcitonin. Clin Chem. 1982 May;28(5):1219–1226. [PubMed] [Google Scholar]
  22. Hillyard C. J., Myers C., Abeyasekera G., Stevvensvenson J. C., Craig R. K., MacIntyre I. Katacalcin: a new plasma calcium-lowering hormone. Lancet. 1983 Apr 16;1(8329):846–848. doi: 10.1016/s0140-6736(83)91387-9. [DOI] [PubMed] [Google Scholar]
  23. Jackson C. E., Block M. A., Greenawald K. A., Tashjian A. H., Jr The two-mutational-event theory in medullary thyroid cancer. Am J Hum Genet. 1979 Nov;31(6):704–710. [PMC free article] [PubMed] [Google Scholar]
  24. Kan Y. W., Dozy A. M. Polymorphism of DNA sequence adjacent to human beta-globin structural gene: relationship to sickle mutation. Proc Natl Acad Sci U S A. 1978 Nov;75(11):5631–5635. doi: 10.1073/pnas.75.11.5631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Melvin K. E., Tashjian A. H., Jr, Miller H. H. Studies in familial (medullary) thyroid carcinoma. Recent Prog Horm Res. 1972;28:399–470. [PubMed] [Google Scholar]
  26. Murray J. M., Davies K. E., Harper P. S., Meredith L., Mueller C. R., Williamson R. Linkage relationship of a cloned DNA sequence on the short arm of the X chromosome to Duchenne muscular dystrophy. Nature. 1982 Nov 4;300(5887):69–71. doi: 10.1038/300069a0. [DOI] [PubMed] [Google Scholar]
  27. Norton J. A., Froome L. C., Farrell R. E., Wells S. A., Jr Multiple endocrine neoplasia type IIb: the most aggressive form of medullary thyroid carcinoma. Surg Clin North Am. 1979 Feb;59(1):109–118. doi: 10.1016/s0039-6109(16)41737-8. [DOI] [PubMed] [Google Scholar]
  28. Riley F. C., Jr, Robertson D. M. Ocular histopathology in multiple endocrine neoplasia type 2b. Am J Ophthalmol. 1981 Jan;91(1):57–64. doi: 10.1016/0002-9394(81)90349-4. [DOI] [PubMed] [Google Scholar]
  29. Roos B. A., Huber M. B., Birnbaum R. S., Aron D. C., Lindall A. W., Lips K., Baylin S. B. Medullary thyroid carcinomas secrete a noncalcitonin peptide corresponding to the carboxyl-terminal region of preprocalcitonin. J Clin Endocrinol Metab. 1983 Apr;56(4):802–807. doi: 10.1210/jcem-56-4-802. [DOI] [PubMed] [Google Scholar]
  30. Rougier P., Parmentier C., Laplanche A., Lefevre M., Travagli J. P., Caillou B., Schlumberger M., Lacour J., Tubiana M. Medullary thyroid carcinoma: prognostic factors and treatment. Int J Radiat Oncol Biol Phys. 1983 Feb;9(2):161–169. doi: 10.1016/0360-3016(83)90093-7. [DOI] [PubMed] [Google Scholar]
  31. Samaan N. A., Anderson G. D., Adam-Mayne M. E. Immunoreactive calcitonin in the mother, neonate, child and adult. Am J Obstet Gynecol. 1975 Mar 1;121(5):622–625. doi: 10.1016/0002-9378(75)90462-7. [DOI] [PubMed] [Google Scholar]
  32. Sisson J. C., Frager M. S., Valk T. W., Gross M. D., Swanson D. P., Wieland D. M., Tobes M. C., Beierwaltes W. H., Thompson N. W. Scintigraphic localization of pheochromocytoma. N Engl J Med. 1981 Jul 2;305(1):12–17. doi: 10.1056/NEJM198107023050103. [DOI] [PubMed] [Google Scholar]
  33. Stevenson J. C., Hillyard C. J., Spanos E., MacIntyre I., Ackroyd N., Lynn J., Brown M. J., Stevenson B. M. Sipple syndrome: marked variability of the disease within a family and implications for management. Postgrad Med J. 1981 Feb;57(664):104–108. doi: 10.1136/pgmj.57.664.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Stewart B. H., Bravo E. L., Haaga J., Meaney T. F., Tarazi R. Localization of pheochromocytoma by computed tomography. N Engl J Med. 1978 Aug 31;299(9):460–461. doi: 10.1056/NEJM197808312990907. [DOI] [PubMed] [Google Scholar]
  35. Telenius-Berg M., Almqvist S., Berg B., Hedner P., Ingemansson S., Tibblin S., Wasthed B. Screening for medullary carcinoma of the thyroid in families with Sipple's syndrome: evaluation of new stimulation tests. Eur J Clin Invest. 1977 Feb;7(1):7–16. doi: 10.1111/j.1365-2362.1977.tb01563.x. [DOI] [PubMed] [Google Scholar]
  36. Valk T. W., Frager M. S., Gross M. D., Sisson J. C., Wieland D. M., Swanson D. P., Mangner T. J., Beierwaltes W. H. Spectrum of pheochromocytoma in multiple endocrine neoplasia. A scintigraphic portrayal using 131I-metaiodobenzylguanidine. Ann Intern Med. 1981 Jun;94(6):762–767. doi: 10.7326/0003-4819-94-6-762. [DOI] [PubMed] [Google Scholar]
  37. Verdy M., Cholette J. P., Cantin J., Lacroix A., Sturtridge W. C. Calcium infusion and pentagastrin injection in diagnosis of medullary thyroid carcinoma. Can Med Assoc J. 1978 Jul 8;119(1):29–35. [PMC free article] [PubMed] [Google Scholar]
  38. Webb T. A., Sheps S. G., Carney J. A. Differences between sporadic pheochromocytoma and pheochromocytoma in multiple endocrime neoplasia, type 2. Am J Surg Pathol. 1980 Apr;4(2):121–126. doi: 10.1097/00000478-198004000-00003. [DOI] [PubMed] [Google Scholar]
  39. Wells S. A., Jr, Baylin S. B., Gann D. S., Farrell R. E., Dilley W. G., Preissig S. H., Linehan W. M., Cooper C. W. Medullary thyroid carcinoma: relationship of method of diagnosis to pathologic staging. Ann Surg. 1978 Sep;188(3):377–383. doi: 10.1097/00000658-197809000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Wells S. A., Jr, Baylin S. B., Leight G. S., Dale J. K., Dilley W. G., Farndon J. R. The importance of early diagnosis in patients with hereditary medullary thyroid carcinoma. Ann Surg. 1982 May;195(5):595–599. doi: 10.1097/00000658-198205000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Wells S. A., Jr, Baylin S. B., Linehan W. M., Farrell R. E., Cox E. B., Cooper C. W. Provocative agents and the diagnosis of medullary carcinoma of the thyroid gland. Ann Surg. 1978 Aug;188(2):139–141. doi: 10.1097/00000658-197808000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Wolfe H. J., Delellis R. A. Familial medullary thyroid carcinoma and C cell hyperplasia. Clin Endocrinol Metab. 1981 Jul;10(2):351–365. doi: 10.1016/s0300-595x(81)80027-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES